PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97810745 |
Filing Date: 02/24/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97810745 |
---|---|
MARK INFORMATION | |
*MARK | TRIVENI |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | TRIVENI |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Amagma, Inc. |
*MAILING ADDRESS | 100 Beaver Street, Suite 307 |
*CITY | Waltham |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02453 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | |
*IDENTIFICATION | Pharmaceutical, therapeutic and biopharmaceutical agents; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies; research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Christina M. Licursi |
ATTORNEY DOCKET NUMBER | M16022000000 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Wolf, Greenfield & Sacks, P.C. |
STREET | 600 Atlantic Avenue |
CITY | Boston |
STATE | Massachusetts |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 02210 |
PHONE | 617-646-8000 |
FAX | 617-646-8646 |
EMAIL ADDRESS | cxltrademarks@wolfgreenfield.com |
OTHER APPOINTED ATTORNEY | Saad Alam, Michael A. Albert, Nicole Davis Amar, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Aya Cieslak-Tochigi, Bryan S. Conley, Gregory F. Corbett, William L. Czaplyski, Cara B. Dawson, Trevor R. Day, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Matthew O. Duffey, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Edward R. Gates, Jean Ge, David S. Gesner, Richard F. Giunta, Gregory J. Gonsalves, Matthew H. Grady, Patricia L. Granahan, Blaine M. Hackman, Philip J. Hamzik, James M. Hanifin, Jr., Steven F. Hannigan, John S. Harmon, Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Quincy L. Kayton, Hunter D. Keeton, Alexandra K. Kim, Jessamine M. Lee, Kevin Y. Li, Lin Li, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Flora Luo, Yue Matthew Ma, Kevin MacDonald, Robert T. Maldonado, John L. Marquardt, Kira-Khanh McCarthy, William R. McClellan, Marie A. McKiernan, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Usha K. M. Parker, Zachary P. Piccolomini, Michael J. Pomianek, Curtis R. Powell, Randy J. Pritzker, Haiou Qin, Stephen S. Rabinowitz, Michael N. Rader, Sushmitha Rajeevan, Suresh Rav, Laura B. Rogers, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia A. Sayour, Amanda Slade, Nathan R. Speed, Charles T. Steenburg, Charlotte R. Stewart-Sloan, John L. Strand, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Andrew R. Varrenti, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Anne E. Weeks, John L. Welch, Adam R. Wichman, Andrew W. Williams, Chelsea E. Witte-Garcia, Douglas R. Wolf, Jie Xiang, Daniel W. Young, Lock See Yu-Jahnes, Adam Z. Zeiger, William Wei Zhang, Norman H. Zivin |
CORRESPONDENCE INFORMATION | |
NAME | Christina M. Licursi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cxltrademarks@wolfgreenfield.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
ORIGINAL PDF FILE | hw_1736820178-154109630_. _M1602.20000US00_TRIVENI_ -_signed.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0006.JPG | |
SIGNATORY'S NAME | Nicholas Scarchilli |
SIGNATORY'S POSITION | CBO, Amagma |
SIGNATURE METHOD | Handwritten |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97810745 |
Filing Date: 02/24/2023 |
The applicant's current Correspondence Information: |
Christina M. Licursi |
PRIMARY EMAIL FOR CORRESPONDENCE: cxltrademarks@wolfgreenfield.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |